CHROMOLOGIC LLC — Department of Defense SBIR Phase II: A13-082
CHROMOLOGIC LLC — SBIR Phase II award from Department of Defense.
- Amount
- $999,988
- Agency
- Department of Defense · Defense Health Program
- Program / Phase
- SBIR · Phase II
- Topic
- A13-082
- Solicitation
- 2013.2
- NAICS
- —
- Place of performance
- CA
- Period
- 2015-09-25 → 2018-02-27
Description
ChromoLogic LLC (CL) is developing a Spectroscopic System for Therapeutic Drug Monitoring (THERASPEC), to meet the Armys need for a compact, robust system to assess the peak and trough therapeutic drug concentrations in blood to provide real-time TDM in fixed and field medical facilities. The THERASPEC prototype is based on spectroscopic